Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited has released a presentation detailing its financial performance and condition, highlighting non-GAAP financial measures such as EBITDA and NPAT. The report excludes certain costs to provide a like-for-like comparison with previous periods, indicating a focus on transparency and accurate financial reporting. This announcement may impact stakeholders by providing insights into the company’s financial health and operational efficiency.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.15 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a range of products and services including pharmaceuticals, medical equipment, and consumer products. The company focuses on serving the healthcare and animal care markets across Australia and New Zealand.
Average Trading Volume: 106,804
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$7.28B
Learn more about EBO stock on TipRanks’ Stock Analysis page.